Immunic Inc Celiac Disease R&D Webcast Transcript
Good morning, everybody. I would like to welcome you to Immunic Celiac Disease Research and Development webcast to discuss current pathways for drug development and persistent disease activity despite gluten-free diet as the unmet medical need. My name is Jessica Breu, Head of Investor Relations and Communications at Immunic. I will also be the moderator on today's webcast.
As always, in the beginning of our webcast, I will walk you through a couple of organizational items first. Please note that all participants will be in listen-only mode, and this event is being recorded. During and after today's presentation, there will be an opportunity to ask questions. (Operator Instructions).
Before we begin, I also would like to remind you that this presentation may contain forward-looking statements. Such statements can be identified by words such as may, will, expect, anticipate, estimate, or words with a similar meaning, and such statements involve a number of risks and uncertainties that could cause Immunic's actual results to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
